Phoenix Financial’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-54,502
Closed -$180K 333
2019
Q4
$180K Sell
54,502
-9,771
-15% -$31.1K 0.01% 188
2019
Q3
$186K Buy
+64,273
New +$181K 0.01% 180

Phoenix Financial's FOMX Position: Q1 2020 in Review

Phoenix Financial sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 54,502 shares — an estimated $180K sold.

Phoenix Financial first reported a position in FOMX in Q3 2019 and held it in 2 quarters. The position peaked at $186K in Q3 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Phoenix Financial reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Phoenix Financial sold 54,502 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $180K.
  • Phoenix Financial first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2019 and held it in 2 quarters.
  • Phoenix Financial's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $186K in Q3 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Phoenix Financial's 13F filing for Q1 2020, filed 20 May 2020.